Stoll, B. J. et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126, 443–456 (2010).

Article  PubMed  Google Scholar 

Abman, S. H. et al. Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. J. Pediatr. 181, 12–28.e1 (2017).

Article  PubMed  Google Scholar 

Pierro, M., Van Mechelen, K., van Westering-Kroon, E., Villamor-Martínez, E. & Villamor, E. Endotypes of Prematurity and Phenotypes of Bronchopulmonary Dysplasia: Toward Personalized Neonatology. J. Pers. Med. 12, 687 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Cakir, U., Tayman, C., Tugcu, A. U. & Yildiz, D. Role of Systemic Inflammatory Indices in the Prediction of Moderate to Severe Bronchopulmonary Dysplasia in Preterm Infants. Arch. Bronconeumol. 59, 216–222 (2023).

Article  PubMed  Google Scholar 

Balany, J. & Bhandari, V. Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia. Front. Med. 2, 90 (2015).

Article  Google Scholar 

Garg, P. M. et al. Clinical Correlates of Moderate-to-Severe Bronchopulmonary Dysplasia in Preterm Infants following Surgical Necrotizing Enterocolitis. Am. J. Perinatol. 41, 1348–1358 (2024).

Article  PubMed  Google Scholar 

Doyle, L. W. et al. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 117, 75–83 (2006).

Article  PubMed  Google Scholar 

Bulbul, A., Bacak, T. & Avsar, H. Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia. Med. Bull. Sisli Etfal Hosp. 57, 171–181 (2023).

Google Scholar 

Puia-Dumitrescu, M. et al. Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants. JAMA Netw. Open 5, e221947 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Deterding, R. et al. Nintedanib in children and adolescents with fibrosing interstitial lung diseases. Eur. Respir. J. https://doi.org/10.1183/13993003.01512-2022 (2022).

Kumar, V. H., Lakshminrusimha, S., El Abiad, M. T., Chess, P. R. & Ryan, R. M. Growth Factors in Lung Development. In Advances in Clinical Chemistry vol. 40 261–316 (Elsevier, 2005).

Ratner, V. et al. Hypoxic Stress Exacerbates Hyperoxia-Induced Lung Injury in a Neonatal Mouse Model of Bronchopulmonary Dysplasia. Neonatology 95, 299–305 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Velten, M., Heyob, K. M., Rogers, L. K. & Welty, S. E. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. J. Appl. Physiol. 108, 1347–1356 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Check, J. et al. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J. Perinatol. J. Calif. Perinat. Assoc. 33, 553–557 (2013).

CAS  Google Scholar 

Mestan, K. K. et al. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. J. Pediatr. 185, 33–41 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar